Aflac
NYSE: AFL
$125.63 ▲ +1.29  (+1.03%)
At close: Jul 24, 2026 · 3:59 PM UTC
Financial Ratios
Market Cap63.80 Bn
P/E13.76
P/S3.85
Div. Yield0.02
ROIC (Qtr)0.00
Revenue Growth (1y) (Qtr)27.90
Add ratio to table…

About

Aflac Incorporated provides financial protection through supplemental health and life insurance products in Japan and the United States. The company’s mission is to give policyholders cash benefits quickly when they face illness or injury so they can focus on recovery rather than financial stress. Aflac designs its policies to complement primary medical coverage by paying benefits regardless of other insurance. The firm is licensed to operate in all fifty states the…

Read more ↓
Sector: Financial Services Industry: Insurance - Life CIK: 0000004977

Investment Thesis

▲ Bull case
  • Aflac's strategic shift toward external reinsurance in Japan represents a significant, underappreciated catalyst for long-term earnings diversification and capital efficiency, as management explicitly framed it as a platform ready to scale with attractive IRRs despite initial immaterial impacts. The transaction with Japan Post Insurance, while currently generating mid-single-digit million-dollar earnings drag, is designed to transition toward neutrality as policies reach paid-up status, with Max Broden emphasizing that such deals can become "immediately accretive to our earnings profile" over time due to the company's AA-rated balance sheet and expertise in navigating the Japanese market. This initiative addresses the persistent drag from underlying earned premium decline in Japan (-1.3% yen terms) by creating a parallel growth engine that leverages Aflac's strength in third-sector protection without relying solely on organic new business sales, which remain robust at +25.5% driven by Onsen Tallett and Miraito products. Crucially, the reinsurance strategy diversifies risk exposure beyond traditional insurance underwriting into mortality, longevity, and spread risks, enhancing the resilience of Aflac Japan's earnings profile against demographic and interest rate headwinds. Management's confidence in this approach—citing their "balance sheet that is quite attractive for counterparties" and a "platform ready to do so"—suggests the market is underestimating the potential for this to evolve into a meaningful contributor to Japan segment profitability within 2-3 years, especially as underlying earned premium growth inflects positive once new business sales sustainably offset lapsation and paid-up policy effects. The unspoken opportunity lies in how this strategy could unlock higher sustainable ROE in Japan by reducing reliance on volatile new business acquisition costs while tapping into Japan Post's vast customer base, a point Virgil Miller hinted at when noting the company's methodical approach to reinvesting in core agent productivity (16% conversion rate, 8% productivity gain) which could synergize with reinsurance-driven scale.
  • The U.S. group business is exhibiting structural, durable growth that significantly outperforms the stagnant core agent segment, with Virgil Miller revealing that group life, absence, and disability lines grew 25% and group business collectively gained 12.4% in Q1—figures that were underemphasized relative to the headline 2.9% overall sales increase. This divergence is critical because the group business benefits from lower distribution costs, higher persistency potential through employer-sponsored models, and direct ties to expanding state-mandated programs like Maine's Paid Family and Medical Leave (PFML), which Aflac now administers for over 500,000 workers via a newly opened South Portland office. Unlike the core agent business, which remains "slightly down to flat" despite recruitment investments, the group segment leverages Aflac's administrative services expertise—generating approximately $90 million in fees from servicing over 3 million constituents—to create sticky, high-margin revenue streams less susceptible to individual agent turnover or commission pressure. The Maine PFML partnership exemplifies a hidden catalyst: as more states adopt similar legislation, Aflac's position as the No. 1 supplemental health insurer and proven administrator allows it to capture administrative service premiums and cross-sell voluntary products at scale, with Virgil Miller explicitly stating they oversee services for entities like Connecticut and are looking to expand into Maine. This is not cyclical but structural, driven by demographic trends (aging workforce, rising out-of-pocket medical costs) and regulatory tailwinds that increase demand for income protection during leave periods—precisely where Aflac's group disability and absence products provide value. Management's disciplined focus on converting new agents (16% rate) and boosting productivity (8% gain) in the core channel, while important, is overshadowed by the group business's ability to deliver consistent premium persistency (79.3%) and net earned premium growth (3.5%) without relying on volatile individual agent performance, making the U.S. segment's growth profile more resilient than the market assumes.
  • Aflac's capital position is substantially stronger than regulatory metrics suggest, creating significant latent capacity for value-accretive deployment that the market is ignoring due to overreliance on headline leverage and ESR ratios. While the adjusted leverage ratio of 21.2% sits within the 20%-25% target and the Economic Solvency Ratio (ESR) stands at 227% (243% with undertaking specific parameter), these figures mask the true flexibility derived from $3.4 billion in unencumbered liquidity—$2.4 billion above the $1 billion minimum—and the company's intentional yen-denominated debt strategy (65% of debt in yen) as part of an enterprise hedging program. Max Broden explicitly stated they have "no real plans to increase our leverage per se," not because capacity is lacking, but because they prioritize returning capital to shareholders ($1.3 billion via buybacks and dividends in Q1) while maintaining tactical flexibility for opportunistic deployments like external reinsurance. The real strength lies in the runoff nature of the Corporate & Other segment, which generated breakeven pretax earnings despite runoff blocks decaying at ~8% annually, indicating that the core insurance operations are generating excess capital far beyond what is needed to sustain current operations. Furthermore, the combined RBC ratio of ~560% and the ability to utilize reinsurance to "create in the near term, more capital and eventually further liquidity" imply that Aflac could meaningfully increase shareholder returns or pursue strategic M&A without breaching risk thresholds. The market's focus on transient pressures—such as the $19 million loan charge-offs and $24 million real estate owned impairments from commercial real estate—overlooks management's conviction that these assets' intrinsic value exceeds current distressed valuations, a view supported by securities impairment reversals in Japan FSA (net realized gain of JPY 66 million). This capital elasticity, combined with a 12.8% adjusted ROE (16.4% ex-FX) and 43-year dividend streak, positions AFLAC to compound shareholder value through buybacks even in modest growth environments, a lever the market underestimates given its focus on short-term earnings volatility from reserve remeasurement and lapse activity.
▼ Bear case
  • Aflac Japan's underlying earned premium decline remains a structural, unresolved issue that management is inadequately addressing despite robust new sales growth, as the persistent -1.3% yen-term trend (underlying earned premium) signals that new business growth is not yet translating into in-force premium growth due to elevated lapse and reissue activity and policies reaching paid-up status. While sales surged 25.5% driven by Onsen Tallett and Miraito, Max Broden conceded that achieving flat earned premium requires approximately JPY 90 billion in annual sales—far above the current JPY 74 billion baseline and even the aspirational JPY 80 billion target Daniel Amos cited—leaving a significant gap that suggests the current product mix and distribution strategy may not be sufficiently sticky or profitable to overcome lapsation. The company's reliance on lapse and reissue activity, particularly among younger customers seeking better coverage (as discussed with Tom Gallagher), creates a temporary sales boost but risks eroding long-term profitability if new policies are written at lower margins or with higher acquisition costs, a concern hinted at when Broden noted that while lapse/reissue activity may balance IRRs over time, a snapshot of a lapsed policy shows "obviously... that IRR is a little bit lower than originally assumed." Furthermore, the benefit ratio improvement in Japan (62.9%, down 2.9 pts) was flattered by reserve remeasurement gains contributing 0.7 percentage points, meaning the underlying trend is less favorable than reported, and the company's own guidance of a 60%-63% full-year range implies limited further upside from current levels. The external reinsurance strategy, while positioned as strategic, remains immature and immaterial to earnings, with Broden admitting initial negative impacts will last "the next couple of quarters," and there is no clear timeline for when it becomes accretive—leaving investors to rely on faith in a strategy that has yet to prove it can offset the core business's inability to grow earned premium organically.
  • The U.S. segment's expense ratio deterioration and margin compression reveal emerging cost pressures that could undermine profitability despite stable top-line growth, as the 0.7 percentage point increase in the expense ratio to 38.3%—driven by higher DAC amortization, commissions, and advertising spend—directly contributed to the 0.4 percentage point decline in pretax margin to 20.4%, a trend management attributed partly to "timing of advertising and investment spend" but which may reflect structural shifts in customer acquisition costs. Virgil Miller's admission that the core agent business remains "slightly down to flat" despite a 16% new agent conversion rate and 8% productivity gain underscores the difficulty of growing this channel, suggesting that investments in onboarding and enrollment process improvements are not yielding the expected returns in a competitive labor market where recruiting remains "tough." More critically, the benefit ratio's strength in Q1 (47.2%, down 0.5 pts) was heavily inflated by reserve remeasurement gains impacting the ratio by approximately 230 basis points—80 basis points above plan—meaning the underlying benefit ratio was closer to 48%, leaving minimal room for improvement given the full-year guidance range of 42%-52%. This implies that as these temporary gains reverse, the U.S. benefit ratio could deteriorate toward the top end of guidance, especially if claims experience normalizes or worsens due to rising medical utilization, a risk not adequately addressed when Pablo Singzon questioned whether the "too good" start would persist. Combined with Adjusted net investment income in the U.S. declining 0.5% due to lower short-term rates (only partially offset by variable income), the segment faces a double headwind of rising costs and potentially normalizing profitability, making the current pretax margin level unsustainable without further expense discipline or claims favorability—neither of which management has convincingly signaled is achievable beyond the current quarter.
  • Aflac's capital return strategy, while impressive in scale ($1.3 billion in Q1), risks overextending the company's financial flexibility by prioritizing shareholder returns over reinvestment in growth opportunities or buffer-building against latent risks, particularly given the deteriorating trends in commercial real estate and the immaturity of the Japan reinsurance initiative. The $19 million in loan portfolio charge-offs and $24 million in real estate owned impairments—explicitly tied to "depressed commercial real estate valuations"—are not isolated events but symptoms of a broader sector stress that management acknowledges does not reflect "the true intrinsic value" of holdings, yet they continue to manage these assets "through this cycle" without a clear plan to mitigate further losses if valuations remain depressed or worsen. This is compounded by the Corporate & Other segment's decline from a $43 million gain to breakeven, driven by lower investment income and runoff blocks, indicating that the holding company's ability to generate excess capital from non-core assets is diminishing. While unencumbered liquidity remains strong at $3.4 billion, the company's deliberate choice to deploy $1 billion in buybacks and $315 million in dividends—rather than bolster reserves against potential real estate losses or accelerate investment in the Japan reinsurance platform—suggests a preference for short-term shareholder appeasement over long-term resilience. Max Broden's statement that external reinsurance "will consume capital" but won't alter shareholder return plans implies that even as this strategic initiative scales, it will be funded without reducing the capital return trajectory, potentially leaving the balance sheet less equipped to handle simultaneous stressors such as a prolonged commercial real estate downturn, a reversal in Japan's benefit ratio trends, or a failure of the core agent business to regain growth traction—a scenario the market is ignoring by focusing solely on the headline capital return figures without questioning their sustainability amid accumulating operational and investment risks.

Reinsurance Premiums for Insurance Companies, by Product Segment Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Insurance - Life
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 PUK Prudential Plc 75.05 Bn13.616.534.46 Bn
2 AFL Aflac Inc 63.80 Bn13.763.85-
3 MET Metlife Inc 60.34 Bn17.570.850.70 Bn
4 MFC Manulife Financial Corp 52.65 Bn16.01-4.69 Bn
5 UNM Unum Group 14.19 Bn18.641.243.76 Bn
6 PRI Primerica, Inc. 9.76 Bn51.355.470.60 Bn
7 JXN Jackson Financial Inc. 8.17 Bn-19.440.752.08 Bn
8 LNC Lincoln National Corp 7.81 Bn4.790.416.37 Bn